| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | reduced fertility | ASPM CACNA1A RSPO2 ANO5 SMARCAD1 FAU XRCC5 CSGALNACT1 EHD4 FANCA | 2.01e-06 | 844 | 27 | 10 | MP:0001921 |
| MousePheno | reduced male fertility | 4.62e-05 | 352 | 27 | 6 | MP:0001922 | |
| MousePheno | periodontium inflammation | 5.36e-05 | 6 | 27 | 2 | MP:0030132 | |
| MousePheno | abnormal chromosome stability | 6.59e-05 | 115 | 27 | 4 | MP:0010094 | |
| MousePheno | decreased litter size | 7.07e-05 | 380 | 27 | 6 | MP:0001935 | |
| MousePheno | abnormal litter size | 9.27e-05 | 399 | 27 | 6 | MP:0001933 | |
| MousePheno | abnormal female reproductive system physiology | 1.75e-04 | 876 | 27 | 8 | MP:0003699 | |
| MousePheno | chromosome breakage | 2.25e-04 | 62 | 27 | 3 | MP:0004028 | |
| MousePheno | reduced female fertility | 2.27e-04 | 296 | 27 | 5 | MP:0001923 | |
| MousePheno | decreased maxillary shelf size | 2.77e-04 | 13 | 27 | 2 | MP:0009897 | |
| Domain | - | 4.01e-04 | 18 | 31 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 4.01e-04 | 18 | 31 | 2 | IPR020901 | |
| Domain | KU | 4.01e-04 | 18 | 31 | 2 | SM00131 | |
| Domain | BPTI_KUNITZ_2 | 4.48e-04 | 19 | 31 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 4.48e-04 | 19 | 31 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 4.48e-04 | 19 | 31 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 6.60e-04 | 23 | 31 | 2 | IPR002223 | |
| Domain | SNF2_N | 1.28e-03 | 32 | 31 | 2 | PF00176 | |
| Domain | SNF2_N | 1.28e-03 | 32 | 31 | 2 | IPR000330 | |
| Domain | Channel_four-helix_dom | 4.02e-03 | 57 | 31 | 2 | IPR027359 | |
| Domain | - | 4.02e-03 | 57 | 31 | 2 | 1.20.120.350 | |
| Domain | - | 6.69e-03 | 74 | 31 | 2 | 3.40.50.410 | |
| Domain | VWA | 8.54e-03 | 84 | 31 | 2 | SM00327 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 25677777 | ||
| Pubmed | 7.19e-06 | 42 | 31 | 3 | 34244791 | ||
| Pubmed | Unified rhombic lip origins of group 3 and group 4 medulloblastoma. | 7.68e-06 | 5 | 31 | 2 | 36131015 | |
| Pubmed | Analysis of Human Nuclear Protein Complexes by Quantitative Mass Spectrometry Profiling. | 7.68e-06 | 5 | 31 | 2 | 29655301 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.07e-05 | 332 | 31 | 5 | 32786267 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 1.36e-05 | 349 | 31 | 5 | 25665578 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.82e-05 | 1353 | 31 | 8 | 29467282 | |
| Pubmed | ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules. | 2.15e-05 | 8 | 31 | 2 | 27562601 | |
| Pubmed | 3.25e-05 | 419 | 31 | 5 | 15635413 | ||
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 37738575 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 38199563 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.89e-05 | 759 | 31 | 6 | 35915203 | |
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 36793866 | ||
| Pubmed | 5.05e-05 | 12 | 31 | 2 | 20823249 | ||
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 12124384 | ||
| Pubmed | 5.96e-05 | 13 | 31 | 2 | 38019816 | ||
| Pubmed | 6.03e-05 | 85 | 31 | 3 | 23055939 | ||
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 27974163 | ||
| Pubmed | Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair. | 9.16e-05 | 16 | 31 | 2 | 31980815 | |
| Pubmed | A new mouse model of ARX dup24 recapitulates the patients' behavioral and fine motor alterations. | 9.16e-05 | 16 | 31 | 2 | 29659809 | |
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 27806305 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 28272472 | ||
| Pubmed | 1.45e-04 | 20 | 31 | 2 | 34237032 | ||
| Pubmed | 1.52e-04 | 116 | 31 | 3 | 21549307 | ||
| Pubmed | Sin3a is essential for the genome integrity and viability of pluripotent cells. | 1.92e-04 | 23 | 31 | 2 | 22206758 | |
| Pubmed | 2.05e-04 | 330 | 31 | 4 | 32529326 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.09e-04 | 989 | 31 | 6 | 36424410 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 2.11e-04 | 1425 | 31 | 7 | 30948266 | |
| Pubmed | 2.28e-04 | 25 | 31 | 2 | 39271675 | ||
| Pubmed | 3.70e-04 | 157 | 31 | 3 | 30186101 | ||
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 4.24e-04 | 34 | 31 | 2 | 16889989 | |
| Pubmed | 4.37e-04 | 731 | 31 | 5 | 29298432 | ||
| Pubmed | Single-cell transcriptomic analysis of mouse neocortical development. | 4.66e-04 | 170 | 31 | 3 | 30635555 | |
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 4.75e-04 | 36 | 31 | 2 | 29089422 | |
| Pubmed | 5.25e-04 | 177 | 31 | 3 | 26206133 | ||
| Pubmed | 5.30e-04 | 38 | 31 | 2 | 34059773 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.42e-04 | 179 | 31 | 3 | 36261009 | |
| Pubmed | 5.78e-04 | 183 | 31 | 3 | 36129980 | ||
| Pubmed | Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. | 6.17e-04 | 41 | 31 | 2 | 15561718 | |
| Pubmed | 6.79e-04 | 43 | 31 | 2 | 26030138 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 7.64e-04 | 468 | 31 | 4 | 36042349 | |
| Pubmed | 8.38e-04 | 208 | 31 | 3 | 11790298 | ||
| Pubmed | 8.59e-04 | 483 | 31 | 4 | 36912080 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 8.68e-04 | 1294 | 31 | 6 | 30804502 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.67e-06 | 152 | 31 | 4 | 669d8f12fdb110ed72f4e5348b7b5350144a061c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.24e-06 | 192 | 31 | 4 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.24e-06 | 192 | 31 | 4 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | B_cell_maturation-Naive_B_cell|World / Lineage and Cell class | 9.24e-06 | 192 | 31 | 4 | 58267a11c938a380c6e26f4e4ce63f3b4be79fdc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.63e-06 | 194 | 31 | 4 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.82e-06 | 195 | 31 | 4 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-05 | 198 | 31 | 4 | 89e25687b614525548279e5fa293c66f5c4abec3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.04e-05 | 198 | 31 | 4 | a14d16d4755bd523d66e3b55e7d78cbb5359acfc | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.06e-05 | 199 | 31 | 4 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-05 | 199 | 31 | 4 | 3b2bd3caf4d189a1726a737b0121860b265eec04 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 133 | 31 | 3 | 8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 138 | 31 | 3 | a88c3ae56b0af60f6e87cabade4f21e2bbb336f2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-04 | 142 | 31 | 3 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 148 | 31 | 3 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 148 | 31 | 3 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.65e-04 | 154 | 31 | 3 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 156 | 31 | 3 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 156 | 31 | 3 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-04 | 160 | 31 | 3 | 8396afbc7d919ba190863d50aa0ef8b9942a9866 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 164 | 31 | 3 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | tumor_Lung-B_lymphocytes-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 2.02e-04 | 165 | 31 | 3 | 3d010a66abac3961cc99f20b1459cf0eb0f7510d | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.13e-04 | 168 | 31 | 3 | c51244b4bdbfd961e2725306aa9cb25dd66d58bd | |
| ToppCell | LAM-Lymphoid-B-cell-1|LAM / Condition, Lineage and Cell class | 2.20e-04 | 170 | 31 | 3 | 2b822a95a8d7ee193d40231418d6bd4cf9662842 | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 171 | 31 | 3 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 171 | 31 | 3 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 171 | 31 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 171 | 31 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 172 | 31 | 3 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 172 | 31 | 3 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 172 | 31 | 3 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 173 | 31 | 3 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 174 | 31 | 3 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | mild-Lymphocytic-B_cells_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.52e-04 | 178 | 31 | 3 | c6fb21401ad802a57e4e4f5a1723c42779fdb33e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-04 | 179 | 31 | 3 | 593fc323b28304a57ae162f64b0890b893fff446 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 2.56e-04 | 179 | 31 | 3 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 179 | 31 | 3 | 708fc0b8ffcb5fac43c52541acb6671fe1cfbb0d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 180 | 31 | 3 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | (2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 2.65e-04 | 181 | 31 | 3 | ad14c7111d4fb924afd233cb114447f195373a7c | |
| ToppCell | BL-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-04 | 181 | 31 | 3 | e3add2412c9f8eddfb77e0fbcd66fe57b23ae513 | |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-B|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-04 | 182 | 31 | 3 | dc6b5ce410c1a7cade60ae17cbbe8548c088cba8 | |
| ToppCell | control-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.69e-04 | 182 | 31 | 3 | 8e96a9dd70814cb0925776613b3a12026d455cad | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.74e-04 | 183 | 31 | 3 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 184 | 31 | 3 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | Bac-SEP-Lymphocyte-B-B_naive|Bac-SEP / Disease, Lineage and Cell Type | 2.82e-04 | 185 | 31 | 3 | 4d9e1eeb353c0b1f82f557856e99c8bf04aa2a7f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 185 | 31 | 3 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 185 | 31 | 3 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 2.87e-04 | 186 | 31 | 3 | a5c0bd4f6a7542f67d478dcdc0645ae6d927a395 | |
| ToppCell | COVID-19-lung-Plasmablasts|lung / Disease (COVID-19 only), tissue and cell type | 2.87e-04 | 186 | 31 | 3 | 81caf67da9fed09c77b7ddcab9b0b8e4fab2de97 | |
| ToppCell | Healthy-MAIT|Healthy / disease group, cell group and cell class | 2.87e-04 | 186 | 31 | 3 | 028061f06d86e75cb06db56b199594b80f23fa58 | |
| ToppCell | 343B-Lymphocytic-B_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 186 | 31 | 3 | 4d339d27e0aa18096554c8325107327b68511fa3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 186 | 31 | 3 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 343B-Lymphocytic-B_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 186 | 31 | 3 | f76b904aa4cbbd0405bf75ffce69ddceae1af89a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 187 | 31 | 3 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 187 | 31 | 3 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.92e-04 | 187 | 31 | 3 | dda43cc4983f1c11a2258bbce9f805db4125322c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.92e-04 | 187 | 31 | 3 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Control-B_naive-5|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.92e-04 | 187 | 31 | 3 | 8c48d67435e168edb892217b3f82c74f2dcedc14 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 187 | 31 | 3 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Control-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type | 2.92e-04 | 187 | 31 | 3 | 90c9b1a51539838323325f563be4adf5fdf1b38f | |
| ToppCell | URO-Lymphocyte-B-B_naive|URO / Disease, Lineage and Cell Type | 2.92e-04 | 187 | 31 | 3 | 9ed6a39aae7126ddbd01aec3376113b6b4517383 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-04 | 188 | 31 | 3 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-04 | 188 | 31 | 3 | fe08277d5aa693a2e12786738d12ec6390e8d13d | |
| ToppCell | LAM-Lymphoid-B-cell-1|Lymphoid / Condition, Lineage and Cell class | 3.01e-04 | 189 | 31 | 3 | ceae675a769b0b01b9d0f27e9a21133959f7a7b3 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.01e-04 | 189 | 31 | 3 | 159b0979c93b7d98aaeeb43fba5983a9f67b9c9d | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.01e-04 | 189 | 31 | 3 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | metastatic_Brain-T/NK_cells-CD4+_Th|metastatic_Brain / Location, Cell class and cell subclass | 3.01e-04 | 189 | 31 | 3 | a2b00fbe7b7b15db3fce88a56cbac0ef2917332c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.01e-04 | 189 | 31 | 3 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.01e-04 | 189 | 31 | 3 | b4237437452f86e745b91285980c48a02a95f4c6 | |
| ToppCell | COVID-19-lung-Plasmablasts|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.01e-04 | 189 | 31 | 3 | fdf6c945b352614885e646a5ef4bc576dee73895 | |
| ToppCell | Healthy-MAIT|World / disease group, cell group and cell class | 3.01e-04 | 189 | 31 | 3 | 2404254b7a31b4a931841232e07462a3ca855ad4 | |
| ToppCell | Severe-MAIT|World / Disease group and Cell class | 3.05e-04 | 190 | 31 | 3 | 7a92e0d6a021be23125495927b8571e25c83204a | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 3.05e-04 | 190 | 31 | 3 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | b65383e256b04122500b742caeed0b807793851e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.05e-04 | 190 | 31 | 3 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 190 | 31 | 3 | 89095d3e023269d89c82e3a73550f869e3f34201 | |
| ToppCell | Severe-MAIT|Severe / Disease group and Cell class | 3.05e-04 | 190 | 31 | 3 | 1c063dc1b62d9f9912aaf8d0297555a6545f5550 | |
| ToppCell | (4)_B_mantle|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.10e-04 | 191 | 31 | 3 | 5dab7f26c59838080787efad963b9cfcfa9a5f13 | |
| ToppCell | CV-Moderate-0|Moderate / Virus stimulation, Condition and Cluster | 3.10e-04 | 191 | 31 | 3 | 6776bcc4c1915f0c1062002ff7746f20ceb725f4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Follicular_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.10e-04 | 191 | 31 | 3 | 06edf2e9b50ea20060648d41fa42ee16086fdf42 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.10e-04 | 191 | 31 | 3 | b374676ac90572d65895052d46469906e2b6fd93 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-B_naive|ICU-NoSEP / Disease, Lineage and Cell Type | 3.10e-04 | 191 | 31 | 3 | f430961a94890fe8755d22e53836be39cb08e153 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Follicular_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.10e-04 | 191 | 31 | 3 | f400fce79aacf029e20b6dca59d3e17bb2375f28 | |
| ToppCell | COVID-19_Moderate-CD4+_Tcm|World / disease group, cell group and cell class | 3.15e-04 | 192 | 31 | 3 | 5f94310f1470487816fce697ffcdc2627fc66878 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.15e-04 | 192 | 31 | 3 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-04 | 192 | 31 | 3 | 7aa8585e08dfbee0acbaef5f8f3817ab3ab5af25 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 192 | 31 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-04 | 192 | 31 | 3 | badf72a52eafb0269391d907ece6b1696684adce | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.15e-04 | 192 | 31 | 3 | 800edadd1d1ba6b7e0a0398030dd4b61c9c480c7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-04 | 193 | 31 | 3 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.20e-04 | 193 | 31 | 3 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-04 | 193 | 31 | 3 | 95ec708d963e9411e2dcf65650ae71a26e9d0e7f | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.20e-04 | 193 | 31 | 3 | b637e1c47a98009e7d19a6daac78f888fd12748f | |
| ToppCell | tumor_Lung-B_lymphocytes-Follicular_B_cells|tumor_Lung / Location, Cell class and cell subclass | 3.20e-04 | 193 | 31 | 3 | d0cb4bfc11491c903cb4cc0f823dd1ee239cf5c4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.20e-04 | 193 | 31 | 3 | d5d188a314da1b4c8390276d88173c09dd7ce4bf | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 193 | 31 | 3 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.20e-04 | 193 | 31 | 3 | d0d0835304647758e6ad4348402a4f76a76137a0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-04 | 193 | 31 | 3 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Follicular_B_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.25e-04 | 194 | 31 | 3 | 05453f8c4d7f742b41d647d574a28555bf78ae39 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-04 | 194 | 31 | 3 | 24f9de4781666c96c4a2d04f8a444543dbd99cbe | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.25e-04 | 194 | 31 | 3 | a3192698248561462d8d3bdaeabdff563a07019f | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 2.79e-05 | 8 | 30 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | rectum cancer (is_implicated_in) | 3.58e-05 | 9 | 30 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | daytime rest measurement | 2.19e-04 | 295 | 30 | 4 | EFO_0007828 | |
| Disease | Ataxia, Spinocerebellar | 5.49e-04 | 34 | 30 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 2 | 5.49e-04 | 34 | 30 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 5.49e-04 | 34 | 30 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 5.49e-04 | 34 | 30 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 5.49e-04 | 34 | 30 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 5.49e-04 | 34 | 30 | 2 | C0752124 | |
| Disease | drug dependence | 5.82e-04 | 35 | 30 | 2 | EFO_0003890 | |
| Disease | Spinocerebellar Ataxia Type 4 | 5.82e-04 | 35 | 30 | 2 | C0752122 | |
| Disease | Malignant neoplasm of salivary gland | 9.63e-04 | 45 | 30 | 2 | C0220636 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNRLVFSVMREGRQK | 1396 | Q14146 | |
| NNFRTFFQALMLLFR | 1736 | O00555 | |
| KQGRRMFPFLSFNIN | 291 | O95936 | |
| FNLFLRRRLMFQKNQ | 51 | Q75V66 | |
| KRVDKFRQFMQNFRE | 271 | Q8TDX6 | |
| FNEMNSRRRKAQFFL | 121 | Q9NVT9 | |
| FLQMAVYRRRFVQQK | 2846 | Q8IZT6 | |
| QRFLAQLRKYFNMRV | 301 | P36021 | |
| QLRKYFNMRVFRQRT | 306 | P36021 | |
| NILRDRFKSFQRRNM | 436 | Q9NZM5 | |
| LYVFMGRNFQERLIR | 301 | P25089 | |
| RIAFNREQRMFKRVG | 161 | Q9UIS9 | |
| RKLSRFGNAFLNRFM | 126 | Q9H223 | |
| KQEQERVMFRRAQFL | 471 | Q9UIX4 | |
| RNFFCLKDNGQIRFM | 266 | Q3SYG4 | |
| RKLANQKRFSEFMRQ | 141 | Q13519 | |
| VLNVLKRVFGMFRQA | 316 | O43613 | |
| MFVLRGFQKNSDLRR | 241 | O15360 | |
| RNTFKRVRNGFLMRK | 2496 | P12111 | |
| RVRNGFLMRKVAVFF | 2501 | P12111 | |
| FNARQRKAFLNAIMR | 1416 | Q14839 | |
| IRQAMAKNRLQFVRF | 76 | Q5TDP6 | |
| MNLFNLDRFRFEKRN | 1 | Q9H4L7 | |
| KNTRYFRQRLQEMGF | 436 | Q9NUV7 | |
| QQKLFFFLRREGMRQ | 56 | Q6UXX9 | |
| KLDFRRQQMQDFFLA | 176 | Q9BXP5 | |
| REQQDLLFRFMNFLK | 341 | Q9Y5W7 | |
| KNRMQRFYFDNREGV | 476 | Q8TBZ2 | |
| IMKRFFFNIFTRQCE | 66 | P10646 | |
| AKRRMQYNRRFVNVV | 106 | P62861 | |
| LFMFFKGRIQRLECQ | 316 | Q8N584 | |
| KRFMQRIGLQFHQRT | 391 | A6NGD5 | |
| VQRRFFMGNQVLKVF | 351 | P13010 |